Robert A. Wascher, MD, FACS
Clinical Advisor & Oncology Consultant
Dr. Wascher is a noted surgical oncologist, cancer researcher, professor, and author. Dr. Wascher received his M.D. degree (magna cum laude) from the Creighton University School of Medicine. Dr. Wascher’s research has focused on the detection of early cancer recurrence using molecular biology techniques, as well as in other areas of cancer biology, diagnosis, and treatment. Dr. Wascher is also the author of the new comprehensive cancer prevention book, "A Cancer Prevention Guide for the Human Race," as well as the author of a widely read weekly global health information column (Weekly Health Update).
Selected Abstracts, Publications & Book Chapters by Dr. Wascher:
Crane-Okada R, Wascher R, Giuliano A. Long-Term Morbidity of Sentinel Node Biopsy versus Complete Axillary Dissection for Unilateral Breast Cancer. Ann Surg Oncol. 2008; 15:1996-2005.
Sabnani I, Varguese J, Wascher R, Youngworth H, Tsang P. Multiple synchronous unusual extranodal sites of relapse in a patient with mantle cell lymphoma. Clin Adv Hematol Oncol. 2007; 5:797-803.
Coviello LC, Wascher RA. Hereditary neoplasia syndromes and the role of the surgeon. Fam Cancer 2007; 2008;7:97-102.
Wascher RA, Rosenbaum EH, Andrews A, et al.: Post-Breast Therapy Pain Syndrome in Rosenbaum EH, Spiegel D, Fobair P, Gautier H (eds.): Everyone’s Guide to Cancer Survivorship—A Road Map for Better Health. Kansas City, Andrews McMeel Publishing, LLC, 2007, pp 169-172.
Takeuchi H, Wascher RA, Kuo C, Turner RR, Hoon DS. Molecular diagnosis of micrometastasis in the sentinel lymph node. Cancer Treat Res. 2005; 127:221-252.
Wascher RA. Pitfalls in the Use of RT-PCR as a Prognostic Indicator in Melanoma. J Clin Oncol. 2005; 23:3863-3864.
Antedomenico E, Wascher RA. A case of mistaken identity: Giant cystic pheochromocytoma. Curr Surg. 2005; 62:193-198.
Takeuchi H, Wascher RA, Kuo C, Turner RT, Hoon DS: Molecular diagnosis of micrometastasis in the sentinel lymph node, in Leong SP, Kitagawa Y, Kitajima M (eds): Selective Sentinel Lymphadenectomy for Human Solid Cancer. New York, NY, Springer Science+Business Media, Inc., 2005, pp 221-252.
Wascher RA. The impact of Internet outreach on the wellbeing of postmastectomy breast cancer survivors. Proc of the Amer Soc Clin Oncol 2004.
Wascher RA, Morton DL, Gerami M, Kuo C, Elashoff RM, Wang HJ, Hoon DS. Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with polyvalent melanoma cell vaccine. J Clin Oncol. 2003; 21:2558-2563.
Wascher RA, Huynh KT, Giuliano AE, Hansen NM, Singer FR, Elashoff D, Hoon DS. Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. Clin Cancer Res. 2003; 9:1427-1435.
Wascher RA: Overview of the sentinel lymph node concept. Cancersupportivecare.com & Cancerlynx.com 2002.
Wascher RA: Postmastectomy pain syndromes: A surgeon’s perspective. Cancersupportivecare.com & Cancerlynx.com 2002.
Wascher RA, Bostick PJ, Huynh KT, Turner R, Qi K, Giuliano AE, Hoon DS. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes. Br J Cancer 2001; 85:1340-1346.
Hoon DS, Kuo CT, Wascher RA, Fournier P, Wang HJ, O'Day SJ. Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients. J Invest Dermatol 2001; 117:375-378.
Wascher RA, Lee M Y-T. Recurrent cutaneous leiomyosarcoma: Case report and review of the literature. Cancer 1992; 70:490-2. |